R A Hromas - JoVE Visualize

Showing results (1-10 of 13) with videos related to

Pageof 2

Sort By:

Journal of Neuro-Oncology|January 1, 1986

Anguidine potentiates cis-platinum in human brain tumor cellsR A Hromas, W K Yung

The American Journal of Gastroenterology|June 1, 1985

Clinical and pathological comparison of young adult women with hepatocellular carcinoma with and without exposure to oral contraceptivesR A Hromas, J Srigley, J L Murray

Cancer Letters|August 1, 1987

Decreased cisplatin uptake by resistant L1210 leukemia cellsR A Hromas, J A North, C P Burns

Research Communications in Chemical Pathology and Pharmacology|November 1, 1980

Flow microfluorometric analysis of the cell cycle phase cytotoxicity of ARA-CR A Hromas, D E Markel, V E Scholes

Blood|December 12, 2001

Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migrationK W Christopherson, J J Campbell, R A Hromas

Oncogene|December 22, 1999

The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth controlZ Topcu, D L Mack, R A Hromas, et al.

Cancer Letters|January 1, 1987

Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cellsR A Hromas, P A Andrews, M P Murphy, et al.

Chronobiologia|October 1, 1981

Flow cytometric analysis of the effect of ara-C on the chronobiology of bone marrow DNA synthesisR A Hromas, J T Hutchins, D E Markel, et al.

Experimental Hematology|August 1, 1994

Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell lineH G Derigs, A Reifel-Miller, K Kaushansky, et al.

Cancer Research|October 1, 1989

Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytesD Gailani, F J Cadwell, P S O'Donnell, et al.

Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:

Pageof 2

Journal of Neuro-Oncology|January 1, 1986

Anguidine potentiates cis-platinum in human brain tumor cellsR A Hromas, W K Yung

The American Journal of Gastroenterology|June 1, 1985

Clinical and pathological comparison of young adult women with hepatocellular carcinoma with and without exposure to oral contraceptivesR A Hromas, J Srigley, J L Murray

Cancer Letters|August 1, 1987

Decreased cisplatin uptake by resistant L1210 leukemia cellsR A Hromas, J A North, C P Burns

Research Communications in Chemical Pathology and Pharmacology|November 1, 1980

Flow microfluorometric analysis of the cell cycle phase cytotoxicity of ARA-CR A Hromas, D E Markel, V E Scholes

Blood|December 12, 2001

Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migrationK W Christopherson, J J Campbell, R A Hromas

Oncogene|December 22, 1999

The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth controlZ Topcu, D L Mack, R A Hromas, et al.

Cancer Letters|January 1, 1987

Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cellsR A Hromas, P A Andrews, M P Murphy, et al.

Chronobiologia|October 1, 1981

Flow cytometric analysis of the effect of ara-C on the chronobiology of bone marrow DNA synthesisR A Hromas, J T Hutchins, D E Markel, et al.

Experimental Hematology|August 1, 1994

Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell lineH G Derigs, A Reifel-Miller, K Kaushansky, et al.

Cancer Research|October 1, 1989

Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytesD Gailani, F J Cadwell, P S O'Donnell, et al.

Pageof 2